KEGG   DRUG: Insulin degludec and insulin aspart (genetical recombination)
Entry
D10570            Mixture   Drug                                   
Name
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination);
Ryzodeg (TN)
Component
Insulin degludec (genetical recombination) [DR:D09727], Insulin aspart (genetical recombination) [DR:D04475]
Class
Antidiabetic agent
 DG01636  Insulin preparation
Remark
Therapeutic category: 2492
ATC code: A10AD06
Product: D10570<JP>
Efficacy
Antidiabetic, Insulin receptor agonist
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10A INSULINS AND ANALOGUES
    A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
     A10AD06 Insulin degludec and insulin aspart
      D10570  Insulin degludec (genetical recombination) and insulin aspart (genetical recombination) <JP>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Insulins
   Insulin, Long-acting
    Insulin Aspart/ Insulin Degludec
     D10570  Insulin degludec (genetical recombination) and insulin aspart (genetical recombination)
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  24  Hormones
   249  Miscellaneous
    2492  Pancreatic hormones
     D10570  Insulin degludec (genetical recombination) and insulin aspart (genetical recombination)
Drug groups [BR:br08330]
 Antidiabetic agent
  DG01636  Insulin preparation
   D10570  Insulin degludec and insulin aspart (genetical recombination)
Drug classes [BR:br08332]
 Antidiabetic agent
  DG01636  Insulin preparation
   D10570  Insulin degludec and insulin aspart (genetical recombination)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10570
Other DBs
PubChem: 254741532
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system